Marshall Wace
TRDA icon

Marshall Wace’s Entrada Therapeutics TRDA Stock Holding History

Marshall Wace’s Portfolio TRDA Stock Details TRDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$679K Buy
53,764
+33,107
+160% +$379K ﹤0.01% 2317
2025
Q4 		$212K Buy
+20,657
New +$174K ﹤0.01% 2577
2024
Q4 		– Sell
-100,106
Closed -$1.6M – 3011
2024
Q3 		$1.6M Buy
100,106
+34,163
+52% +$538K ﹤0.01% 1448
2024
Q2 		$940K Buy
65,943
+14,220
+27% +$202K ﹤0.01% 1718
2024
Q1 		$733K Buy
+51,723
New +$731K ﹤0.01% 1779
2023
Q3 		– Sell
-11,312
Closed -$171K – 2688
2023
Q2 		$171K Sell
11,312
-6,015
-35% -$82.9K ﹤0.01% 2264
2023
Q1 		$251K Buy
+17,327
New +$231K ﹤0.01% 2350

Other funds holding TRDA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return